Literature DB >> 17220318

In vitro induction of immunoglobulin A (IgA)- and IgM-secreting plasma blasts by cholera toxin depends on T-cell help and is mediated by CD154 up-regulation and inhibition of gamma interferon synthesis.

Sergio Arce1, Hesham F Nawar, Gwendolin Muehlinghaus, Michael W Russell, Terry D Connell.   

Abstract

Cholera toxin (CT) and the type II heat-labile enterotoxins (LT-IIa and LT-IIb) are potent immunological adjuvants which are hypothesized to enhance the production of antibody (Ab)-secreting cells, although their mechanisms of action are not fully understood. The treatment of splenic cells with concanavalin A (ConA) plus CT enhanced the production of immunoglobulin A (IgA) and IgM by dividing cells that expressed high levels of major histocompatibility complex class II (MHC-II), CD19, and CD138 and low levels of B220 a phenotype characteristic of plasma blasts. LT-IIa or LT-IIb moderately enhanced IgA and IgM production without enhancing plasma blast differentiation. CT up-regulated CD25, CD69, CD80, CD86, and MHC-II in isolated B cells but failed to induce proliferation or differentiation. The treatment of unfractionated splenic cells with ConA plus CT induced B-cell proliferation and differentiation, but the elimination of CD4(+) T cells inhibited this effect. CT treatment of ConA-activated CD4(+) T cells up-regulated CD134 and CD154, whereas the blockage of CD40-CD154 interactions inhibited the induction of plasma blasts and Ig synthesis. The treatment of unfractionated splenic cells with CT, LT-IIa, or LT-IIb enhanced the production of interleukin-6 (IL-6) and IL-10, whereas the production of gamma interferon was inhibited in both CD4(+) and CD8(+) T cells mostly by CT. Thus, major regulatory effects of CT on lymphocytes are likely exerted early during the induction of immune responses when B and T cells initially encounter antigen. Neither LT-IIa or LT-IIb had these effects, indicating that type II enterotoxins augment Ab responses by other mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17220318      PMCID: PMC1828582          DOI: 10.1128/IAI.01367-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

Review 1.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  The ADP-ribosylating CTA1-DD adjuvant enhances T cell-dependent and independent responses by direct action on B cells involving anti-apoptotic Bcl-2- and germinal center-promoting effects.

Authors:  L Agren; E Sverremark; L Ekman; K Schön; B Löwenadler; C Fernandez; N Lycke
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

3.  Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants.

Authors:  K L Kellar; R R Kalwar; K A Dubois; D Crouse; W D Chafin; B E Kane
Journal:  Cytometry       Date:  2001-09-01

4.  Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo.

Authors:  K M Smith; L Pottage; E R Thomas; A J Leishman; T N Doig; D Xu; F Y Liew; P Garside
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

Review 5.  Location is everything: lipid rafts and immune cell signaling.

Authors:  Michelle Dykstra; Anu Cherukuri; Hae Won Sohn; Shiang-Jong Tzeng; Susan K Pierce
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

6.  Maintenance of serological memory by polyclonal activation of human memory B cells.

Authors:  Nadia L Bernasconi; Elisabetta Traggiai; Antonio Lanzavecchia
Journal:  Science       Date:  2002-12-13       Impact factor: 47.728

Review 7.  Extrafollicular antibody responses.

Authors:  Ian C M MacLennan; Kai-Michael Toellner; Adam F Cunningham; Karine Serre; Daniel M-Y Sze; Elina Zúñiga; Matthew C Cook; Carola G Vinuesa
Journal:  Immunol Rev       Date:  2003-08       Impact factor: 12.988

Review 8.  Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections.

Authors:  G Hajishengallis; S Arce; C M Gockel; T D Connell; M W Russell
Journal:  J Dent Res       Date:  2005-12       Impact factor: 6.116

9.  The source of early IFN-gamma that plays a role in Th1 priming.

Authors:  G Das; S Sheridan; C A Janeway
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

10.  Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.

Authors:  M Martin; D J Metzger; S M Michalek; T D Connell; M W Russell
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

View more
  12 in total

1.  Cholera toxin impairs the differentiation of monocytes into dendritic cells, inducing professional antigen-presenting myeloid cells.

Authors:  Filippo Veglia; Ester Sciaraffia; Antonella Riccomi; Dora Pinto; Donatella R M Negri; Maria Teresa De Magistris; Silvia Vendetti
Journal:  Infect Immun       Date:  2010-12-13       Impact factor: 3.441

Review 2.  Type II heat-labile enterotoxins: structure, function, and immunomodulatory properties.

Authors:  George Hajishengallis; Terry D Connell
Journal:  Vet Immunol Immunopathol       Date:  2012-09-26       Impact factor: 2.046

3.  LT-IIc, a new member of the type II heat-labile enterotoxin family, exhibits potent immunomodulatory properties that are different from those induced by LT-IIa or LT-IIb.

Authors:  Hesham F Nawar; Christopher J Greene; Chang Hoon Lee; Lorrie M Mandell; George Hajishengallis; Terry D Connell
Journal:  Vaccine       Date:  2010-11-21       Impact factor: 3.641

4.  Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxins.

Authors:  W Zhao; Z Zhao; M W Russell
Journal:  Mol Oral Microbiol       Date:  2011-03-31       Impact factor: 3.563

5.  Binding to gangliosides containing N-acetylneuraminic acid is sufficient to mediate the immunomodulatory properties of the nontoxic mucosal adjuvant LT-IIb(T13I).

Authors:  Hesham F Nawar; Charles S Berenson; George Hajishengallis; Hiromu Takematsu; Lorrie Mandell; Ragina L Clare; Terry D Connell
Journal:  Clin Vaccine Immunol       Date:  2010-04-14

Review 6.  Toxins-useful biochemical tools for leukocyte research.

Authors:  Susana Cubillos; Johannes Norgauer; Katja Lehmann
Journal:  Toxins (Basel)       Date:  2010-03-26       Impact factor: 4.546

7.  In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli.

Authors:  Shuang Liang; Kavita B Hosur; Hesham F Nawar; Michael W Russell; Terry D Connell; George Hajishengallis
Journal:  Vaccine       Date:  2009-05-29       Impact factor: 3.641

Review 8.  Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins.

Authors:  Terry D Connell
Journal:  Expert Rev Vaccines       Date:  2007-10       Impact factor: 5.217

9.  Cholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytes.

Authors:  Donatella R M Negri; Dora Pinto; Silvia Vendetti; Mario Patrizio; Massimo Sanchez; Antonella Riccomi; Paolo Ruggiero; Giuseppe Del Giudice; Maria Teresa De Magistris
Journal:  Infect Immun       Date:  2009-02-17       Impact factor: 3.441

10.  Heat-Labile Toxin from Enterotoxigenic Escherichia coli Causes Systemic Impairment in Zebrafish Model.

Authors:  Camila Henrique; Maria Alice Pimentel Falcão; Luciana De Araújo Pimenta; Adolfo Luís Almeida Maleski; Carla Lima; Thais Mitsunari; Sandra Coccuzzo Sampaio; Mônica Lopes-Ferreira; Roxane Maria Fontes Piazza
Journal:  Toxins (Basel)       Date:  2021-06-12       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.